HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Learning from failure.

Abstract
The launch of a new initiative to share data from failed clinical trials of investigational drugs for Alzheimer's disease provides both a promising opportunity to improve drug development in this field, as well as a novel mechanism to learn more from negative trials in general.
Authors
JournalNature reviews. Drug discovery (Nat Rev Drug Discov) Vol. 9 Issue 7 Pg. 499 (Jul 2010) ISSN: 1474-1784 [Electronic] England
PMID20614555 (Publication Type: Editorial)
Chemical References
  • Indoles
  • Nootropic Agents
  • latrepirdine
Topics
  • Alzheimer Disease (drug therapy)
  • Clinical Trials as Topic
  • Clinical Trials, Phase III as Topic
  • Databases, Bibliographic
  • Indoles (therapeutic use)
  • Nootropic Agents (therapeutic use)
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: